Market Place
Sourcing Support
Q Biomed Announces Addition Of Dollar Asset Value In Maniin Research
14 Nov 2022 //
PRNEWSWIRE
Q Biomed Announces Issuance Of Patent For Groundbreaking Gdf15 Biomarker
27 Sep 2022 //
PRNEWSWIRE
Q BioMed Inc. Provides Update to Shareholders
29 Jul 2022 //
PRNEWSWIRE
Q BioMed announces publication of pre-clinical research for liver cancer
26 Jul 2022 //
PRNEWSWIRE
Q BioMed Outlines Strategy and Value Proposition in Multi-Billion Dollar Markets
06 May 2022 //
PRNEWSWIRE
Q BioMed says publication of research showing augmented efficacy of Uttroside-B
16 Mar 2022 //
PRNEWSWIRE
Q BioMed says Initial $500k Order of Strontium89 to Chinese Market
07 Mar 2022 //
PRNEWSWIRE
Q BioMed Outlines Strategic Direction for 2022
14 Feb 2022 //
PRNEWSWIRE
Q BioMed Updates on COVID19 Therapeutic Development and Clinical Trials - MAN-19
22 Sep 2021 //
PRNEWSWIRE
Q BioMed inks license agreement with Clionix to distribute Strontium89
14 Jul 2021 //
PHARMABIZ
Q BioMed inks license agreement with Clionix to distribute Strontium89
14 Jul 2021 //
PHARMABIZ
Q BioMed inks license agreement with Clionix to distribute Strontium89
14 Jul 2021 //
PHARMABIZ
Q BioMed Agreement with Clionix for the Distribution and Sales of Strontium89
12 Jul 2021 //
PRNEWSWIRE
Q BioMed Insider to Invest up to $30M in the Company
11 May 2021 //
PRNEWSWIRE
Q BioMed`s Uttroside-B Receives U.S. FDA Orphan Drug Designation
27 Jan 2021 //
PRNEWSWIRE
Q BioMed`s Uttroside-B Receives Additional Patent Coverage in Canada and Japan
26 Jan 2021 //
PRNEWSWIRE
Q BioMed Updates Shareholders at Year End
29 Dec 2020 //
PRNEWSWIRE
Q BioMed Technology Partner Mannin Research Inc. Announced as Member
21 Dec 2020 //
PRNEWSWIRE
Q BioMed Announces Strontium89 Initial Uptake and Momentum in US and Europe
15 Sep 2020 //
PRNEWSWIRE
Q BioMed Announces Strontium89 will be available as of September 2020 through
11 Aug 2020 //
PRNEWSWIRE
Q BioMed Launches New Website Strontium89.com and Digital for Strontium89
15 May 2020 //
PRNEWSWIRE
Human Trials Forge Ahead For Development of COVID-19 Vaccine For Global
22 Apr 2020 //
PR NEWSWIRE
Q BioMed Initiates Rapid Development of Novel COVID-19 Therapeutics
22 Apr 2020 //
PR NEWSWIRE
Q BioMed Enters $7.8M Financial Restructuring
08 Apr 2020 //
CONTRACTPHARMA
Q BioMed Expands Leadership Team With Chief Commercial Officer
30 Mar 2020 //
PR NEWSWIRE
Q BioMed Launches Non-opioid Treatment for Metastatic Bone Pain
13 Feb 2020 //
PR NEWSWIRE
Q BioMed Partner Mannin Research Developing Potential Treatment for Coronavirus
04 Feb 2020 //
PR NEWSWIRE
Mannin Presents +Ve Data for Treatment of Kidney Injury with Tie2 Activator
26 Nov 2019 //
PR NEWSWIRE
Q BioMed Announces $7.5M Grant Benefiting its Preclinical Product DevP Pipeline
05 Nov 2019 //
PR NEWSWIRE
Q BioMed Announces Commercial Partnership With Jubilant Radiopharma
07 Oct 2019 //
BIOSPACE
